Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Adtran Networks SE is a leading European technology company specializing in the development, manufacture, and sale of optical and Ethernet-based networking solutions. It primarily serves telecommunications carriers, enterprises, service providers, and government agencies by delivering systems for data, storage, voice, and video services across diverse infrastructures. Key product categories include open optical transport, packet edge and aggregation, disaggregated networking, network virtualization, infrastructure assurance, and automated network management. The company holds a global market leadership position with nearly 30% share in optical transmission technology for data center interconnections, driven by megatrends like cloud computing and mobility that demand higher bandwidth and flexible synchronization. Founded in 1994, Adtran Networks SE emphasizes innovation through substantial R&D investments, rapid commercialization of technologies such as 100 Gigabit transmission, and collaborations with network operators. Its solutions support over 250 operators and 10,000 companies worldwide, spanning sectors like communications, internet content, finance, energy, healthcare, and media. With administrative headquarters near Munich and legal domicile in Meiningen, Germany, it employs around 2,000 people and operates through segments including Network Solutions and Services and Support, with a global footprint in Europe, the Americas, and Asia-Pacific.
The business is unprofitable at the operating level (-5.57% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 10.0%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€482M
▲ +10.0% YoY
Net Income (TTM)
-€22M
▲ +65.1% YoY
Op. Margin
-5.57%
▲ +2.6pp YoY
ROIC
-4.62%
▲ +1.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€16M
▲ +2819.1% YoY
Op. Cash Flow (TTM)
€28M
▲ +151.0% YoY
Net Debt
€6M
Cash & Equiv.
€39M
3Y CAGR: -12.2%
Continue Research